Potential Application of SARS-CoV-2 Rapid Antigen Diagnostic Tests for the Detection of Infectious Individuals Attending Mass Gatherings - A Simulation Study
- PMID: 38455312
- PMCID: PMC10911017
- DOI: 10.3389/fepid.2022.862826
Potential Application of SARS-CoV-2 Rapid Antigen Diagnostic Tests for the Detection of Infectious Individuals Attending Mass Gatherings - A Simulation Study
Abstract
Rapid Antigen Diagnostic Tests (RADTs) for the detection of SARS-CoV-2 offer advantages in that they are cheaper and faster than currently used PCR tests but have reduced sensitivity and specificity. One potential application of RADTs is to facilitate gatherings of individuals, through testing of attendees at the point of, or immediately prior to entry at a venue. Understanding the baseline risk in the tested population is of particular importance when evaluating the utility of applying diagnostic tests for screening purposes. We used incidence data from January and from July-August 2021, periods of relatively high and low levels of infection, to estimate the prevalence of infectious individuals in the community at particular time points and simulated mass gatherings by sampling from a series of age cohorts. Nine different illustrative scenarios were simulated, small (n = 100), medium (n = 1,000) and large (n = 10,000) gatherings each with 3 possible age constructs: mostly younger, mostly older or a gathering with equal numbers from each age cohort. For each scenario, we estimated the prevalence of infectious attendees, then simulated the likely number of positive and negative test results, the proportion of cases detected and the corresponding positive and negative predictive values, and the cost per case identified. Our findings suggest that for each reported case on a given day, there are likely to be 13.8 additional infectious individuals also present in the community. Prevalence ranged from 0.26% for "mostly older" events in July-August, to 2.6% for "mostly younger" events in January. For small events (100 attendees) the expected number of infectious attendees ranged from <1 across all age constructs of attendees in July-August, to 2.6 for "mostly younger" events in January. For large events (10,000 attendees) the expected number of infectious attendees ranged from 27 (95% confidence intervals 12 to 45) for mostly older events in July-August, to 267 (95% confidence intervals 134 to 436) infectious attendees for mostly younger attendees in January. Given rapid changes in SARS-CoV-2 incidence over time, we developed an RShiny app to allow users to run updated simulations for specific events.
Keywords: COVID-19; SARS-CoV-2; predictive value; prevalence; rapid antigen test.
Copyright © 2022 McAloon, Dahly, Walsh, Wall, Smyth, More and Teljeur.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Universal screening for SARS-CoV-2 infection: a rapid review.Cochrane Database Syst Rev. 2020 Sep 15;9(9):CD013718. doi: 10.1002/14651858.CD013718. Cochrane Database Syst Rev. 2020. PMID: 33502003 Free PMC article.
-
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z. Trials. 2021. PMID: 33419461 Free PMC article.
-
Negative SARS-CoV-2 PCR or rapid antigen test result and the subsequent risk of being infectious: a mathematical simulation study.BMC Med Res Methodol. 2021 Aug 10;21(1):165. doi: 10.1186/s12874-021-01361-3. BMC Med Res Methodol. 2021. PMID: 34376152 Free PMC article.
-
Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis.Health Technol Assess. 2021 Mar;25(21):1-68. doi: 10.3310/hta25210. Health Technol Assess. 2021. PMID: 33764295 Free PMC article.
-
Travel-related control measures to contain the COVID-19 pandemic: a rapid review.Cochrane Database Syst Rev. 2020 Oct 5;10:CD013717. doi: 10.1002/14651858.CD013717. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2021 Mar 25;3:CD013717. doi: 10.1002/14651858.CD013717.pub2. PMID: 33502002 Updated.
Cited by
-
Assessment of Rapid Antigen Diagnostic Tests at Mass Events: Identifying Optimal Floor Plan Configurations for Enhanced Efficiency.Healthcare (Basel). 2024 Nov 26;12(23):2375. doi: 10.3390/healthcare12232375. Healthcare (Basel). 2024. PMID: 39684997 Free PMC article.
-
To lockdown or not to lockdown: Analysis of the EU lockdown performance vs. COVID-19 outbreak.Front Med Technol. 2022 Oct 21;4:981620. doi: 10.3389/fmedt.2022.981620. eCollection 2022. Front Med Technol. 2022. PMID: 36340587 Free PMC article.
References
-
- Denkinger C. Rapid Antigen Tests for the Detection of SARS-CoV-2 Infection. (2021). Available online at: https://www.klinikum.uni-heidelberg.de/diagnostics-global-health
LinkOut - more resources
Full Text Sources
Miscellaneous